Literature DB >> 23561621

Intravenous rituximab for the treatment of cancer-associated retinopathy.

Chris Or, David R Collins, Andrew B Merkur, Yujuan Wang, Chi-Chao Chan, Farzin Forooghian.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23561621     DOI： 10.1016/j.jcjo.2012.11.010

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN： 0008-4182            Impact factor:   1.882


× No keyword cloud information.
  13 in total

Review 1.  The enigma of autoimmune retinopathy.

Authors:  Farzin Forooghian; Sijia Cao; Jing Cui; Joanne A Matsubara
Journal:  Int Ophthalmol Clin       Date:  2015

2.  Unilateral cancer-associated retinopathy: diagnosis, serology and treatment.

Authors:  Dimitri Roels; Shinji Ueno; Cornelia D Talianu; Dafina Draganova; Mineo Kondo; Bart P Leroy
Journal:  Doc Ophthalmol       Date:  2017-08-16       Impact factor: 2.379

Review 3.  Autoimmune retinopathy.

Authors:  Landon Grange; Monica Dalal; Robert B Nussenblatt; H Nida Sen
Journal:  Am J Ophthalmol       Date:  2013-09-29       Impact factor: 5.258

Review 4.  Autoimmune Retinopathy: Current Concepts and Practices (An American Ophthalmological Society Thesis).

Authors:  H Nida Sen; Landon Grange; Marib Akanda; Austin Fox
Journal:  Trans Am Ophthalmol Soc       Date:  2018-03-08

5.  Electroretinographic improvement after rituximab therapy in a patient with autoimmune retinopathy.

Authors:  Gunay Uludag; Sumru Onal; Serra Arf; Isil Sayman Muslubas; Fatih Selcukbiricik; Aylin Koc Akbay; Nil Molinas Mandel
Journal:  Am J Ophthalmol Case Rep       Date:  2016-03-30

6.  Efficacy of rituximab in non-paraneoplastic autoimmune retinopathy.

Authors:  Katherine Boudreault; Sally Justus; Jesse D Sengillo; Kaspar Schuerch; Winston Lee; Thiago Cabral; Stephen H Tsang
Journal:  Orphanet J Rare Dis       Date:  2017-07-15       Impact factor: 4.123

Review 7.  Impact of Autoantibodies against Glycolytic Enzymes on Pathogenicity of Autoimmune Retinopathy and Other Autoimmune Disorders.

Authors:  Grazyna Adamus
Journal:  Front Immunol       Date:  2017-04-28       Impact factor: 7.561

8.  Rituximab as a monotherapy or in combination therapy for the treatment of non-paraneoplastic autoimmune retinopathy.

Authors:  Arash Maleki; Neerav Lamba; Lina Ma; Stacey Lee; Alexander Schmidt; C Stephen Foster
Journal:  Clin Ophthalmol       Date:  2017-02-17

9.  Retinal imaging with en face and cross-sectional optical coherence tomography delineates outer retinal changes in cancer-associated retinopathy secondary to Merkel cell carcinoma.

Authors:  Nisreen K Mesiwala; Nathan Shemonski; Michelle G Sandrian; Ryan Shelton; Hiroshi Ishikawa; Hussein A Tawbi; Joel S Schuman; Stephen A Boppart; Leanne T Labriola
Journal:  J Ophthalmic Inflamm Infect       Date:  2015-08-19

10.  Recovery of outer retinal laminations on optical coherence tomography after treatment of cancer associated retinopathy.

Authors:  Francisco J Irizarry; Laura J Kopplin; Sherveen S Salek; Grazyna Adamus; Mohamed Saleh; Kristin Biggee; Phoebe Lin; James T Rosenbaum
Journal:  Am J Ophthalmol Case Rep       Date:  2017-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.